Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eucomed's UDI guidance

This article was originally published in The Gray Sheet

Executive Summary

European trade association Eucomed's 1guidance on implementation of Unique Device Identification (UDI), issued July 22, "strongly advocates a standardized approach" based on global standards with regard to UDI. The trade association notes that its members are increasingly using two-dimensional bar codes to identify their products and that these should continue to be used in parallel with radio frequency identification (RFID) as problems with RFID are worked out. Eucomed is also in favor of a risk-based approach to tracking and tracing that focuses on the highest risk devices first and exempts low-risk device categories

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel